BOSTON, Jan. 08, 2026 (GLOBE NEWSWIRE) — Aktis Oncology, Inc. (“Aktis”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed by existing platform technologies, today announced the pricing of its upsized initial public offering of 17,650,000 shares of its common stock at a […]

Aktis Oncology Announces Pricing of its Upsized Initial Public Offering GlobeNewswire January 09, 2026 BOSTON, Jan. 08, 2026 (GLOBE NEWSWIRE) — Aktis Oncology, Inc. (“Aktis”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed by existing platform technologies, today announced the pricing of

Fujitsu Limited today announced that it has jointly developed a new digital learning platform with Japan Airlines Co., Ltd. (JAL) to support educational training improvements at JAL's airport sites. The platform, which leverages Fujitsu's digital learning solution Advanced Teaming Experience Service powered by UMU, began full-scale operation in April 2025. Since the initial roll-out, approximately

Fort Lauderdale, FL, Jan. 08, 2026 (GLOBE NEWSWIRE) — Disclaimer: This article is for informational purposes only. It is not medical advice. Kratom products have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare professional before starting any new supplement. If

Best Kratom Formats Compared: Super Speciosa Consumer Report Examines Powder, Capsules, Gummies, and Extracts as 2026 Searches Rise 2026 Consumer Analysis: Best Kratom Powder, Capsules, Gummies, and Extract Formats from AKA GMP-Qualified, Lab-Tested Super Speciosa GlobeNewswire January 09, 2026 Fort Lauderdale, FL, Jan. 08, 2026 (GLOBE NEWSWIRE) — Disclaimer: This article is for informational purposes

Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Ventyx Biosciences, Inc. (“Ventyx”) (NASDAQ: VTYX), resulting from allegations of providing potentially misleading business information to the investing public. If you have information that could assist in the Ventyx Investigation or if you are a Ventyx investor who suffered a loss and

AUSTIN, Jan. 08, 2026 (GLOBE NEWSWIRE) — Disclaimer: This article is for informational purposes only. It is not medical advice. Sermorelin is a compounded prescription medication requiring evaluation by an independent licensed medical provider. Compounded medications are not FDA-approved as finished products; the FDA does not verify their safety, effectiveness, or quality before they are

ReadyRx Sermorelin: Prescription Telehealth Access in Injectable and ODT Formats — 2026 Platform Analysis of Compounding Standards and Provider Structure Market Analysis: How Three-Entity Telehealth Platforms Handle Prescription Peptide Evaluation, Compounded Medication Dispensing, and Realistic Timeline Variability GlobeNewswire January 09, 2026 AUSTIN, Jan. 08, 2026 (GLOBE NEWSWIRE) — Disclaimer: This article is for informational purposes

At CES 2026, TCL unveiled a range of smart terminal products featuring artificial intelligence technologies, spanning smart displays, mobile devices, wearables, and smart home appliances. TCL is actively integrating capabilities from multiple AI technology partners, including Microsoft, to accelerate AI innovation and multi-scenario applications, delivering more efficient and convenient experiences for users worldwide. Highlights —

Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving New Era Energy & Digital, Inc. (“New Era”) (NASDAQ: NUAI), resulting from allegations of providing potentially misleading business information to the investing public. If you have information that could assist in the New Era Investigation or if you are a New Era